Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10195619rdf:typepubmed:Citationlld:pubmed
pubmed-article:10195619lifeskim:mentionsumls-concept:C0206558lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C2608085lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C1824884lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:10195619lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:10195619pubmed:issue9-10lld:pubmed
pubmed-article:10195619pubmed:dateCreated1999-6-2lld:pubmed
pubmed-article:10195619pubmed:abstractTextDNA molecules complexed with an asialoglycoprotein-polycation conjugate, consisting of asialoorosomucoid (ASOR) coupled to poly-L-lysine, can enter hepatocytes which bear receptors for ASOR. We used this receptor-mediated DNA delivery system to deliver plasmid DNA encoding glycoprotein D (gD) of herpes simplex virus type 1 to ASOR-positive cells. Maximum expression of gD protein was seen at 3 days after injection of this preparation in approximately 13% of cells from BALB/c mice [hepatocytes from mice injected intravenously (i.v.) or peritoneal exudate cells from mice injected intraperitoneally (i.p.)]. In comparison with mice injected with either the plasmid vector alone or the gD-containing plasmid uncomplexed to ASOR, mice immunized with gD-containing plasmid complexed with ASOR-poly-L-lysine induced marked antigen-specific CTL responses. BALB/c mice immunized with gD-DNA developed a T-cell-mediated CTL response against target cells expressing gD and MHC class II glycoproteins, but not against cells expressing only gD and MHC class I molecules. In C3H mice, gD-DNA induced a T-cell-mediated CTL response against target cells expressing gD and class I MHC molecules. Serum anti-gD antibody in low titers were produced in both strains of mice. DNA complexed with ASOR-poly-L-lysine induced CTL responses in mice.lld:pubmed
pubmed-article:10195619pubmed:languageenglld:pubmed
pubmed-article:10195619pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:citationSubsetIMlld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10195619pubmed:statusMEDLINElld:pubmed
pubmed-article:10195619pubmed:monthMarlld:pubmed
pubmed-article:10195619pubmed:issn0264-410Xlld:pubmed
pubmed-article:10195619pubmed:authorpubmed-author:FinkP SPSlld:pubmed
pubmed-article:10195619pubmed:authorpubmed-author:ChiouH CHClld:pubmed
pubmed-article:10195619pubmed:authorpubmed-author:BerberichS...lld:pubmed
pubmed-article:10195619pubmed:authorpubmed-author:BigleyN JNJlld:pubmed
pubmed-article:10195619pubmed:authorpubmed-author:CruzP EPElld:pubmed
pubmed-article:10195619pubmed:authorpubmed-author:DrydenT DTDlld:pubmed
pubmed-article:10195619pubmed:authorpubmed-author:KhalilP LPLlld:pubmed
pubmed-article:10195619pubmed:issnTypePrintlld:pubmed
pubmed-article:10195619pubmed:day5lld:pubmed
pubmed-article:10195619pubmed:volume17lld:pubmed
pubmed-article:10195619pubmed:ownerNLMlld:pubmed
pubmed-article:10195619pubmed:authorsCompleteYlld:pubmed
pubmed-article:10195619pubmed:pagination1091-9lld:pubmed
pubmed-article:10195619pubmed:dateRevised2006-5-1lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:meshHeadingpubmed-meshheading:10195619...lld:pubmed
pubmed-article:10195619pubmed:year1999lld:pubmed
pubmed-article:10195619pubmed:articleTitleA novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D.lld:pubmed
pubmed-article:10195619pubmed:affiliationDepartment of Microbiology, Wright State University, Dayton, OH 45435, USA.lld:pubmed
pubmed-article:10195619pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195619lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10195619lld:pubmed